Cellu Tissue - Long Island LLC is categorized under in Central Islip, NY and active since 2008.
Cellu Tissue - Long Island LLC was established in 2008, and today employs 1 to 4, earning $20.000.000 to $49.9999.999 per year. This is a business, which does work in the B2B market, and is classified as a , under code number 322291 by the NAICS.
If you are seeking more information, feel free to contact Russell C Taylor at the company’s single location by writing to 555 North Research Place, Central Islip, New York NY 11722 or by phoning (973) 831-2700. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Cellu Tissue - Long Island LLC |
| Contact Person: | Russell C Taylor |
| Address: | 555 North Research Place, Central Islip, New York 11722 |
| Phone Number: | (973) 831-2700 |
| Website Address: | clearwaterpaper.com |
| Annual Revenue (USD): | $20.000.000 to $49.9999.999 |
| Founded: | 2008 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | |
| SIC Code: | 2676 |
| NAICS Code: | 322291 |
| Share This Business: |
Cellu Tissue - Long Island LLC was started in 2008 to provide professional under the SIC code 2676 and NAICS code 322291. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $20.000.000 to $49.9999.999 per annum.
Feel free to contact Russell C Taylor for inquiries that concern Cellu Tissue - Long Island LLC by calling the company number (973) 831-2700, as your correspondence is most welcome. Additionally, the physical location of the single location of Cellu Tissue - Long Island LLC can be found at the coordinates 40.773961,-73.201374 as well as the street address 555 North Research Place in Central Islip, New York 11722.
For its online presence, you may visit Cellu Tissue - Long Island LLC’s website at clearwaterpaper.com and engage with its social media outlets through on Twitter and on Facebook.